Skip to main content
. 2024 Dec 26;17(1):39. doi: 10.3390/cancers17010039

Table 3.

Characterization of reported BRCA variants.

Gene Cases Gene Variant Variant Type ACMG Score Associated
Phenotype
Relevant Literature
BRCA1 3 NM_007300.4:c.5329dup
p.(Gln1777ProfsTer74)
Duplication
frameshift
Pathogenic
(PVS1, PP5, PM2)
TN [4,62,63,64,65]
L-B
NCO
BRCA1 2 NM_007300.4:
c.843_846del
p.(Ser282TyrfsTer15) l
Deletion, frameshift Pathogenic
(PVS1, PP5, PM2)
TN [66,67,68]
TN
BRCA1 1 NM_007300.4:
c.5093_5096del
p.(Thr1698IlefsTer2)
Deletion, frameshift Pathogenic
(PVS1, PP5, PM2)
TN [63,69,70]
BRCA2 1 NM_000059.4:
c.2471T>G
p.(Leu824Ter)
Substitution, Missense Pathogenic
(PVS1, PP5, PM2)
TN [71,72]
BRCA2 1 NM_000059.4:
c.5576_5579del (p.Ile1859fs)
Deletion, frameshift Pathogenic
(PVS1, PP5, PM2)
L-A [73,74,75,76,77]
BRCA2 1 NM_000059.3:
c.8331+1G>Ap.?
Substitution,
Missense
splice site, intron 18
Pathogenic
(PVS1, PP5, PM2)
L-A [78,79,80,81]

Legend: BC = Breast carcinoma; L-A = Luminal A type BC; L-B = Luminal B type BC; NCO = Not Carried Out; T-N = Triple-Negative BC.